Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)

This study is ongoing, but not recruiting participants.

Study NCT00308139 Information provided by Amylin Pharmaceuticals, Inc.

First Received: March 27, 2006 Last Updated: September 30, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	September 2009
Primary Completion Date:	September 2007 (Final data collection date for primary outcome measure)